PHAXIAM Therapeutics S.A. (PHXM) — Free Cash Flow Generation Index

Latest as of December 2012: 1.08x

PHAXIAM Therapeutics S.A. (PHXM) has a Free Cash Flow Generation Index of 1.08x as of December 2012. Free cash flow of €669.80K represents 1% of operating cash flow (€621.40K). Explore PHXM capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

1.08x

Free Cash Flow / Operating CF

Free Cash Flow

€669.80K

EUR

Operating Cash Flow

€621.40K

EUR

Capital Expenditures

€48.40K

EUR

PHAXIAM Therapeutics S.A. Free Cash Flow Generation Index (2012–2012)

Historical FCF Generation Index trend for PHAXIAM Therapeutics S.A. across 1 annual periods. For the full cash flow conversion analysis, see PHAXIAM Therapeutics S.A. operating cash flow efficiency.

Annual Free Cash Flow Generation for PHAXIAM Therapeutics S.A. (2012–2012)

Year-by-year Free Cash Flow Generation Index for PHAXIAM Therapeutics S.A.. Check PHAXIAM Therapeutics S.A. total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Year	FCG Index	Free Cash Flow (EUR)	Operating CF	Capital Expenditures	YoY Change
2012	0.92x	€568.90K	€621.40K	€52.50K	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).